BSE Live
Nov 03, 16:01Prev. Close
156.60
Open Price
156.40
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Nov 03, 15:51Prev. Close
156.86
Open Price
156.09
Bid Price (Qty.)
155.26 (110)
Offer Price (Qty.)
0.00 (0)
| Balance Sheet of Bliss GVS Pharma (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
| 12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
| EQUITIES AND LIABILITIES | ||||||
| SHAREHOLDER'S FUNDS | ||||||
| Equity Share Capital | 10.54 | 10.47 | 10.42 | 10.37 | 10.31 | |
| Total Share Capital | 10.54 | 10.47 | 10.42 | 10.37 | 10.31 | |
| Reserves and Surplus | 1,048.10 | 977.97 | 926.58 | 831.12 | 735.50 | |
| Total Reserves and Surplus | 1,048.10 | 977.97 | 926.58 | 831.12 | 735.50 | |
| Total Shareholders Funds | 1,058.63 | 988.44 | 937.00 | 851.43 | 755.65 | |
| NON-CURRENT LIABILITIES | ||||||
| Long Term Borrowings | 19.67 | 35.10 | 40.69 | 23.22 | 32.49 | |
| Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 3.48 | 7.92 | 7.05 | |
| Other Long Term Liabilities | 12.47 | 9.24 | 2.56 | 3.49 | 1.83 | |
| Long Term Provisions | 4.36 | 2.47 | 2.61 | 1.07 | 2.50 | |
| Total Non-Current Liabilities | 36.51 | 46.80 | 49.34 | 35.71 | 43.87 | |
| CURRENT LIABILITIES | ||||||
| Short Term Borrowings | 31.34 | 30.54 | 36.39 | 62.39 | 35.38 | |
| Trade Payables | 60.32 | 54.47 | 75.87 | 84.21 | 66.78 | |
| Other Current Liabilities | 32.41 | 32.31 | 41.09 | 44.79 | 42.36 | |
| Short Term Provisions | 0.49 | 0.00 | 0.00 | 1.44 | 1.59 | |
| Total Current Liabilities | 124.55 | 117.31 | 153.36 | 192.83 | 146.11 | |
| Total Capital And Liabilities | 1,219.70 | 1,152.55 | 1,139.69 | 1,079.96 | 945.62 | |
| ASSETS | ||||||
| NON-CURRENT ASSETS | ||||||
| Tangible Assets | 367.66 | 329.86 | 324.61 | 223.96 | 173.56 | |
| Intangible Assets | 0.22 | 0.10 | 0.21 | 0.35 | 0.53 | |
| Capital Work-In-Progress | 20.58 | 7.83 | 2.80 | 22.15 | 2.39 | |
| Other Assets | 0.68 | 0.68 | 0.69 | 0.69 | 0.69 | |
| Fixed Assets | 389.15 | 338.47 | 328.30 | 247.16 | 177.18 | |
| Non-Current Investments | 18.69 | 18.69 | 18.26 | 18.26 | 18.30 | |
| Deferred Tax Assets [Net] | 9.09 | 4.12 | 0.00 | 0.00 | 0.00 | |
| Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 1.94 | |
| Other Non-Current Assets | 35.07 | 18.30 | 63.48 | 23.63 | 71.56 | |
| Total Non-Current Assets | 452.01 | 379.57 | 410.04 | 289.05 | 268.98 | |
| CURRENT ASSETS | ||||||
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Inventories | 81.94 | 89.45 | 74.15 | 90.11 | 83.68 | |
| Trade Receivables | 428.25 | 399.51 | 399.06 | 408.82 | 348.68 | |
| Cash And Cash Equivalents | 171.11 | 169.32 | 84.61 | 149.48 | 119.52 | |
| Short Term Loans And Advances | 36.99 | 36.03 | 88.97 | 80.91 | 64.88 | |
| OtherCurrentAssets | 49.40 | 78.67 | 82.86 | 61.58 | 59.88 | |
| Total Current Assets | 767.69 | 772.98 | 729.65 | 790.92 | 676.64 | |
| Total Assets | 1,219.70 | 1,152.55 | 1,139.69 | 1,079.96 | 945.62 | |
| OTHER ADDITIONAL INFORMATION | ||||||
| CONTINGENT LIABILITIES, COMMITMENTS | ||||||
| Contingent Liabilities | 58.52 | 55.82 | 10.09 | 21.81 | 30.06 | |
| CIF VALUE OF IMPORTS | ||||||
| Raw Materials | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Capital Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| EXPENDITURE IN FOREIGN EXCHANGE | ||||||
| Expenditure In Foreign Currency | 112.60 | 89.64 | 122.46 | 95.33 | 74.52 | |
| REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
| Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
| EARNINGS IN FOREIGN EXCHANGE | ||||||
| FOB Value Of Goods | -- | -- | -- | -- | -- | |
| Other Earnings | 615.62 | 560.71 | 561.84 | 579.10 | 381.25 | |
| BONUS DETAILS | ||||||
| Bonus Equity Share Capital | 4.91 | 4.91 | 4.91 | 4.91 | 4.91 | |
| NON-CURRENT INVESTMENTS | ||||||
| Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Non-Current Investments Unquoted Book Value | 18.69 | 18.69 | 18.26 | 18.26 | 18.30 | |
| CURRENT INVESTMENTS | ||||||
| Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
| Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
30.07.2025
Bliss GVS Consolidated June 2025 Net Sales at Rs 207.47 crore, up 12.97% Y-o-Y
30.07.2025
Bliss GVS Standalone June 2025 Net Sales at Rs 163.36 crore, up 9.67% Y-o-Y
13.05.2025
Bliss GVS Standalone March 2025 Net Sales at Rs 156.00 crore, down 4.77% Y-o-Y
13.05.2025
Bliss GVS Consolidated March 2025 Net Sales at Rs 197.99 crore, down 0.07% Y-o-Y